Goldman Sachs’s Akero Therapeutics AKRO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $40.9M | Buy |
765,741
+277,349
| +57% | +$14.8M | 0.01% | 1263 |
|
|
2025
Q1 | $19.8M | Buy |
488,392
+30,868
| +7% | +$1.25M | ﹤0.01% | 1711 |
|
|
2024
Q4 | $12.7M | Sell |
457,524
-204,797
| -31% | -$5.7M | ﹤0.01% | 2144 |
|
|
2024
Q3 | $19M | Sell |
662,321
-120,629
| -15% | -$3.46M | ﹤0.01% | 1775 |
|
|
2024
Q2 | $18.4M | Buy |
782,950
+193,098
| +33% | +$4.53M | ﹤0.01% | 1652 |
|
|
2024
Q1 | $14.9M | Sell |
589,852
-23,423
| -4% | -$592K | ﹤0.01% | 1747 |
|
|
2023
Q4 | $14.3M | Buy |
613,275
+282,190
| +85% | +$6.6M | ﹤0.01% | 1810 |
|
|
2023
Q3 | $31.2M | Buy |
331,085
+122,042
| +58% | +$11.5M | 0.01% | 1194 |
|
|
2023
Q2 | $9.76M | Sell |
209,043
-14,248
| -6% | -$665K | ﹤0.01% | 2061 |
|
|
2023
Q1 | $8.54M | Buy |
223,291
+37,379
| +20% | +$1.43M | ﹤0.01% | 2131 |
|
|
2022
Q4 | $10.2M | Sell |
185,912
-1,932,885
| -91% | -$106M | ﹤0.01% | 2118 |
|
|
2022
Q3 | $72.1M | Buy |
2,118,797
+255,193
| +14% | +$8.69M | 0.02% | 751 |
|
|
2022
Q2 | $0 | Buy |
1,863,604
+770,924
| +71% | – | ﹤0.01% | 5676 |
|
|
2022
Q1 | $15.5M | Sell |
1,092,680
-674,034
| -38% | -$9.56M | ﹤0.01% | 1897 |
|
|
2021
Q4 | $37.4M | Buy |
1,766,714
+1,735,530
| +5,565% | +$36.7M | 0.01% | 1324 |
|
|
2021
Q3 | $697K | Buy |
31,184
+2,610
| +9% | +$58.3K | ﹤0.01% | 4200 |
|
|
2021
Q2 | $709K | Sell |
28,574
-180,853
| -86% | -$4.49M | ﹤0.01% | 4235 |
|
|
2021
Q1 | $6.08M | Sell |
209,427
-40,278
| -16% | -$1.17M | ﹤0.01% | 2530 |
|
|
2020
Q4 | $6.44M | Buy |
249,705
+187,947
| +304% | +$4.85M | ﹤0.01% | 2331 |
|
|
2020
Q3 | $1.9M | Sell |
61,758
-9,013
| -13% | -$278K | ﹤0.01% | 2935 |
|
|
2020
Q2 | $1.76M | Buy |
70,771
+16,108
| +29% | +$401K | ﹤0.01% | 2901 |
|
|
2020
Q1 | $1.16M | Buy |
54,663
+17,777
| +48% | +$377K | ﹤0.01% | 3039 |
|
|
2019
Q4 | $819K | Buy |
36,886
+10,762
| +41% | +$239K | ﹤0.01% | 3422 |
|
|
2019
Q3 | $594K | Sell |
26,124
-32,040
| -55% | -$729K | ﹤0.01% | 3517 |
|
|
2019
Q2 | $1.11M | Buy |
+58,164
| New | +$1.11M | ﹤0.01% | 3129 |
|